Canaloplasty and trabeculotomy with the OMNI^® surgical system in OAG with prior trabecular microbypass stenting.

"Declarations Competing interestsDr. Terveen has received a research grant from Sight Sciences, Drs. Ristvedt, Sarkisian, Vold, and Williamson are consultants and speakers for Sight Sciences and Glaukos. Dr. Sarkisian has an equity interest in Sight Sciences. Drs. Dickerson and Dhamdhere are employees of Sight Sciences, Inc. The other authors have no financial interest. Ethical approvalThe study was reviewed by the Institutional Review Board (WCG IRB, Puyallup, WA, USA; IRB Protocol No: 20213289). All patient data was treated with confidentiality, in accordance with the Declaration of Helsinki. This study is not considered an “Applicable Clinical Trial” under 42 CFR 11.22(b) and is exempt from listing on clinicaltrials.gov. Consent to participateWaiver of consent was granted by the WCG IRB due to the retrospective non-interventional nature of the study. Competing interests Dr. Terveen has received a research grant from Sight Sciences, Drs. Ristvedt, Sarkisian, Vold, and Williamson are consultants and speakers for Sight Sciences and Glaukos. Dr. Sarkisian has an equity interest in Sight Sciences. Drs. Dickerson and Dhamdhere are employees of Sight Sciences, Inc. The other authors have no financial interest."

"Funding This research costs for this study were covered Sight Sciences, Inc."